CBIO ▲ +2.0% - Crescent Biopharma, Inc.
$CBIO - Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors
05-OCT-2026 07:30 AM ET
Share this post
More filings for $CBIO
CBIO ▲ +4.5% - Crescent Biopharma, Inc.Nov 12, 2026CBIO ▲ +1.1% - Crescent Biopharma, Inc.Nov 3, 2026CBIO ▲ +0.9% - Crescent Biopharma, Inc.Nov 2, 2026CBIO - Crescent Biopharma, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026CBIO ▼ -0.7% - Crescent Biopharma, Inc.Oct 15, 2026CBIO ▼ -2.5% - Crescent Biopharma, Inc.Oct 6, 2026
View full $CBIO filing history →💬 Comments
Loading comments…
Leave a comment